AJANTA PHARMA LTD.
Market Cap.(`)
|
30194.81 Cr.
|
P/BV
|
8.46
|
Book Value (`)
|
283.30
|
52 Week High/Low ( ` )
|
2540/1247
|
FV/ML
|
2/1
|
P/E(X)
|
37.00
|
Book Closure
|
08/02/2024
|
EPS (`)
|
64.82
|
Div Yield (%)
|
2.13
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 1113.93 | 745.25 | 909.48 | 900.18 | 663.97 |
| | | | | |
Net CashFlow From Operating Activities | 785.07 | 791.78 | 562.04 | 576.31 | 456.77 |
Net Cash Used In Investing Activities | 65.39 | -559.60 | -74.10 | -282.39 | -224.41 |
Net Cash Used From Financing Activities | -1051.06 | -107.87 | -460.04 | -318.29 | -128.63 |
Foreign Exchange Gains / Losses | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -200.34 | 124.31 | 27.90 | -24.37 | 103.73 |
Cash And Cash Equivalents Begin of Year | 329.83 | 206.36 | 177.51 | 202.36 | 95.16 |
Cash And Cash Equivalents End Of Year | 129.49 | 330.67 | 205.41 | 177.99 | 198.89 |